Versant Venture Capital V L.P. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 8:21 pm Sale |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Versant Venture Capital V L.P. | 382,961 0.800% |
-1,512,041 (-79.79%) |
Filing |
| 2021-02-12 8:27 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Versant Venture Capital V L.P. | 1,895,002 5.800% |
-789,560 (-29.41%) |
Filing |